The indicators of Ki67 in breast cancer are closely related to the clinic pathological characteristics and molecular subtyping, which is not only a reference indicator for the prognosis and individualized treatment of breast cancer patients [4,5] but also of great significance in distinguishing the subtypes of intraluminal breast cancer and determining the optimal treatment scheme [6,7]. Here, MKI67 is linked to breast cancer.